CClinicalTrials.gg
Not yet recruitingNCT07254949VIPERSUpdated Nov 28, 2025

Vision and Proprioception Evaluation With Robotics After Stroke

An observational study in Stroke and Control Condition, sponsored by Dr. Sean Dukelow. Not yet recruiting at 2 sites in Canada. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-11-28.

Sponsored by Dr. Sean Dukelow · Observational

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
425
Ages
18 Years and older
Sex
All
01

Study summary

Stroke is highly prevalent in Canada and can lead to profound upper limb impairments in motor and sensory function, as well and vision. Clinical assessments for these functions often lack sensitivity making detecting impairments and tracking their recovery after stroke difficult. It is known that sensory function and vision interact to inform motor behaviours, yet how each of these modalities might contribute to motor impairments and subsequent recovery after stroke is undetermined.

Using robotics to assess neurologic function after a stroke can be very beneficial, as they can measure on the scale of millimetres and milliseconds which can more easily detect subtle deficits in a persons function. Compared to current clinical tools, robotics offer greater objectivity and reliability, as they do not rely on the examiners clinical experience and/or impression. The use of robotics not only offers a more precise measurement, but robotics assessments can be completed in a relatively short amount of time, in comparison to some of the current clinical assessment tools, which can take along time to complete. In addition to robotics, collecting neuroimaging (MRI/CT) will allow us to relate our robotic and eye-tracking measures to neuroanatomical information about the person's stroke. With this data, we will assess how the brain changes post-stroke in relation to the recovery of motor, sensory and visual functions.

This research will: 1) examine the relationship between visual and proprioceptive impairment on motor and eye movement behaviour over time after stroke, and 2) identify neuroanatomical correlates of visual, proprioceptive and sensory integrative dysfunction that impact motor recovery after stroke and examine the ability of regional damage and network disruption to predict recovery.

Objectives:

  1. Determine the impact of visual field loss and visual neglect in stroke survivors with impaired movement over the first 6 months post-stroke.
  2. Identify the impact of Proprioceptive Impairment and Sensory Integration Impairment on recovery post-stroke using robotics and eye tracking.
  3. Understand the impact of damage to neuroanatomic structures involved in vision, proprioception and sensory integration on motor recovery using MRI after stroke.

The VIPERS study is recruiting both stroke and control participants. Stroke participants are recruited within the first 28 days post-stroke and are assessed longitudinally across the first 6-months post-stroke (four study timepoints). Control participants just complete a single session.

02

Conditions studied

  • Stroke
  • Control Condition

Browse trials for

Keywords

  • Stroke
  • Sensation
  • Movement
  • Vision
  • Robotics
  • Eye-Tracking
  • Imaging
03

In context

Stroke

7,286 studies on the registry are indexed under Stroke; 2,007 are open to participants now.

This study's planned enrollment of 425 is above the median of 160 across 1,692 observational studies indexed under Stroke.

Browse Stroke studies →

Lead sponsor

This is the only study on the registry with Dr. Sean Dukelow as lead sponsor.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

425 participants will be recruited for this study (225 stroke participants and 200 matched control participants who have not experienced a stroke). All participant will be aged 18 or older.

Eligibility criteria

Inclusion criteria for stroke participants:

  • 18 years of age or older
  • First clinical diagnosis of stroke
  • No recent muscle skeletal injuries to the arms, neck, or back
  • No history of other neurological disease/injury (Ie. MS, Parkinson's, Brain Tumour, etc.)
  • Corrected vision 20/50 or better
  • Able to follow multi-step commands.
  • Living independently prior to stroke
  • Can consent to participate in research

Inclusion criteria for control participants:

  • 18 years of age or older
  • No history stroke, or Trans Ischemic Attack (TIA)
  • No recent muscle skeletal injures to the arms, neck, or back
  • No history of other neurological disease/ injury (Ie. MS, Parkinson's, Brain Tumour, etc)
  • No pre-stroke history of eye movement disorders
  • Corrected vision 20/50 or better
  • Able to follow multi-step commands
  • Can consent to participate in research

Exclusion Criteria:

  • Prior history of stroke/significant neurologic problem (e.g. Parkinson's)
  • Symptomatic medical conditions that would interfere with participation (e.g. uncontrolled angina)
  • Contraindications to Magnetic Resonance Imaging (MRI)
  • Pre-stroke history of visual field/oculomotor abnormalities.
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
425 participants (estimated)
Patient registry
No

Groups and cohorts

  • Stroke

    Stroke Participants - Individuals with first time stroke

  • Control

    Control Participants - Individuals not suffering stroke or other neurological disorders

06

What researchers measure

Primary outcomes

  1. Visually Guided Reaching Score

    Time frame: Enrolment to six-months post stroke

Other outcomes

  1. Visually Guided Reaching Score (no vision)

    Time frame: Enrolment to six-months post stroke

  2. Proprioceptive Saccade task scores

    Time frame: Enrolment to six-months post stroke

  3. Arm Movement Matching (vision)

    Time frame: Enrolment to six-months post stroke

  4. Arm Movement Matching

    Time frame: Enrolment to six-months post stroke

  5. Arm position matching (vision)

    Time frame: Enrolment to six-months post stroke

  6. Arm Position Matching Score

    Time frame: Enrolment to six-months post stroke

  7. Visually Guided Reaching Score

    Time frame: From enrolment to six-months post stroke

  8. Anti-saccade task score

    Time frame: Enrolment to six-months post stroke

  9. Pro-saccade task score

    Time frame: Enrolment to six-months post-stroke

  10. Behavioural Inattention Test (BIT)

    Time frame: Enrolment to six-months post-stroke

  11. Visual Impairment Screening Assessment (VISA)

    Time frame: Enrolment to six-months post-stroke

  12. Humphrey's Visual Field Analyzer (VFA)

    Time frame: Enrolment to six-months post stroke

  13. Thumb Localization Test (TLT)

    Time frame: Enrolment to six-months post stroke

  14. Medical Research Council Strength Scale

    Time frame: Enrolment to six-months post stroke

  15. Modified Ashworth Scale (MAS)

    Time frame: Enrolment to six-months post stroke

  16. Fugl-Meyer Assessment-Upper Extremity (FMA-UE)

    Time frame: Enrolment to six-months post stroke

  17. Functional Independence Measure (FIM)

    Time frame: Enrolment to six-months post stroke

07

Study locations

2 sites
  • Carewest Dr. Vernon Fanning Centre
    Calgary, Alberta, Canada
  • Foothills Medical Centre
    Calgary, Alberta, Canada
08

References and documents

Individual participant data

Plan to share: No — Formal data transfer agreements/legal contracts are required to share IPD with other researchers outside of the main study site.

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Nov 28, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07254949
Lead sponsor
Dr. Sean Dukelow
Responsible party
Dr. Sean Dukelow (Principal Investigator, University of Calgary) — Sponsor-investigator
First posted
Nov 28, 2025
Start date
Jan 2026 (estimated)
Primary completion
Jan 2031 (estimated)
Completion
Jun 2031 (estimated)
Last update
Nov 28, 2025

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Nov 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion